Seelos Therapeutics Announces Year-End 2021 Business and Clinical Update
Marijuana Stocks, Finance, & InvestingUncategorized March 7, 2022
Seelos Therapeutics reports progress on several of its drug R&D initiatives, including preparing for a Phase IIb/Phase III trial of SLS-005 for ALS.
Read morePennsylvania’s Medical Cannabis Program Expands Financial Assistance, Research
Marijuana Industry News March 7, 2022
Cannabis with a Conscience: New Delivery Service Connects Sacramento & Butte County Consumers to Sustainable Mendocino Farmers
Marijuana Industry News March 7, 2022
Illinois Bill Would Bar Employers From Firing Employees for Using Cannabis
Marijuana Industry News March 7, 2022
Nevada Cannabis Compliance Board Suspends Cultivator’s Licenses
Marijuana Industry News March 7, 2022
Sugarbud Launches First Cannabis 2.0 and New Multi-Pack Pre-Roll Format Products In Ontario
March 7, 2022
AFC Gamma Expands Existing Senior Secured Credit Facilities With Three Existing Borrowers
March 7, 2022